Home・Elenco Azioni・Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc

Chiusa

SettoreSettore sanitario

579.85 0.47

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

562.67

Massimo

577.67

Metriche Chiave
By Trading Economics
Entrata	85M 1.7B
Vendite	989M 12B
P/E Media del settore	30.845 68.51
EPS	6.03
Rendimento da dividendi	0.31
Margine di Profitto	14.516
Dipendenti	125,000
EBITDA	262M 2.6B

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+6.84% upside

Dividendi
By Acuity
Rendimento da dividendi Media del settore	0.31% 2.29%
Utili prossimi	21 ott 2026
Prossima data del Dividendo	15 ott 2026
Prossima data del' Ex Dividendo	15 set 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	18B 213B
Apertura precedente	579.38
Chiusura precedente	579.85

Notizie sul Sentiment di mercato

By Acuity

27%

73%

79 / 340 Classifica in Healthcare

Thermo Fisher Scientific Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

5 ago 2026, 19:56 UTC

Correlated Moves

News

Stifel raised its price target on Thermo Fisher Scientific to $650, boosting investor sentiment as shares trade higher. Charles River's strong performance may also influence results.

4 ago 2026, 19:36 UTC

News

Correlated Moves

Thermo Fisher Scientific shares are lower amid concerns over organic revenue growth and declining margins, compounded by negative economic data and Bruker Corp's significant drop.

3 ago 2026, 19:26 UTC

Thermo Fisher Scientific Inc. shares are higher today, tracking broader market gains amid falling energy prices and renewed investor confidence. No specific company news identified.

1 ago 2026, 00:01 UTC

Thermo Fisher Scientific Inc shares are trading lower in after-market hours, reflecting a decline during the session despite being above the 20-day moving average.

31 lug 2026, 22:41 UTC

Correlated Moves

Thermo Fisher Scientific Inc. shares are lower in after-market trading, influenced by a broader market decline and rising U.S. Treasury yields amid inflation concerns.

30 lug 2026, 19:09 UTC

Correlated Moves

Thermo Fisher Scientific Inc shares are lower amid mixed economic data, including rising jobless claims and disappointing Q2 GDP growth.

29 lug 2026, 23:16 UTC

Thermo Fisher Scientific shares are trading roughly flat in after-market hours. The stock remains above its 20-day moving average and near its one-month range.

28 lug 2026, 18:06 UTC

News

Social Media

Thermo Fisher Scientific shares reached a 25-week high of $588.48, reflecting strong upward momentum despite a recent pullback from earlier session highs.

27 lug 2026, 18:01 UTC

Thermo Fisher Scientific Inc. shares are lower today amid a broader market reaction to falling oil prices, despite easing geopolitical tensions surrounding Iran.

24 lug 2026, 19:23 UTC

News

Social Media

Thermo Fisher Scientific shares are lower today despite strong Q2 results and revenue of $11.99 billion. Barclays and Deutsche Bank raised price targets to $650 and $635, respectively.

23 lug 2026, 23:01 UTC

Thermo Fisher Scientific shares declined in after-market trading, touching a session low before a slight recovery. The stock remains above its 20-day moving average.

22 lug 2026, 23:02 UTC

Social Media

Thermo Fisher Scientific is set to report earnings, with analysts estimating revenue of $11.71 billion and EPS of $5.72. Shares are higher in after-market trading.

21 lug 2026, 22:01 UTC

Thermo Fisher Scientific shares are higher in after-market hours, supported by positive market sentiment from strong earnings reports, despite recent lower finishes.

20 lug 2026, 19:46 UTC

Shares of Thermo Fisher Scientific Inc. are lower today, reflecting routine intraday fluctuations within the asset's one-month trading range.

Confronto tra pari

Modifica del prezzo

Thermo Fisher Scientific Inc Previsione

Obiettivo di Prezzo

By TipRanks

6.84% in crescita

Previsioni per 12 mesi

Media 617.35 USD 6.84%

Alto 690 USD

Basso 520 USD

Basato su 18 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Thermo Fisher Scientific Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

18 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 18 che hanno fornito valutazioni azionarie a Thermo Fisher Scientific Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

79 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar